Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 521.60
Bid: 521.80
Ask: 522.20
Change: 4.60 (0.89%)
Spread: 0.40 (0.077%)
Open: 519.80
High: 525.00
Low: 517.20
Prev. Close: 517.00
BME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Senior Secured Notes Offering

23 Jan 2017 07:56

RNS Number : 8162U
B&M European Value Retail S.A.
23 January 2017
 

 

 

 

23 January 2017

 

B&M European Value Retail S.A.

 

B&M Launches £250 Million Senior Secured Notes Offering

 

 

THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY, AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF B&M EUROPEAN RETAIL VALUE S.A. THIS ANNOUNCEMENT IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR ANY JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT. 

 

B&M European Value Retail S.A. (the "Company") (BME:LN) announces today that it intends to offer sterling-denominated senior secured notes in an aggregate principal amount of approximately £250 million due 2022 (the "Notes").

 

The Notes will be offered in connection with the refinancing of certain of the Company's existing senior credit facilities. The existing facilities will be replaced by new senior credit facilities, which will include a £300 million term loan facility and £150 million revolving credit facility. If successful, the proceeds from the offering of the Notes, together with the new term loan A facility and cash on hand, will be used to refinance all of the the existing senior facilities, to pay fees and expenses relating to the refinancing, including the offering of the Notes, and for general corporate purposes.

 

This announcement includes inside information which is disclosed in accordance with the Market Abuse Regulation.

 

 

Enquiries

 

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400 Ext 5766

Simon Arora, Chief Executive

Paul McDonald, Chief Financial Officer

Steve Webb, Investor relations Director

investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Maitland

Robbie Hynes

bmstores-maitland@maitland.co.uk

 

 

Important Notice

 

No communication and no information in respect of the offering by B&M European Value Retail S.A. of notes described in this announcement (the "Notes") may be distributed to the public in any jurisdiction where a registration or approval is required. No steps have been or will be taken in any jurisdiction where such steps would be required. The offering or sale of the Notes may be subject to specific legal or regulatory restrictions in certain jurisdictions. B&M European Value Retail S.A. takes no responsibility for any violation of any such restrictions by any person.

This announcement is not a prospectus within the meaning of Directive 2003/71/EC of the European Parliament ant the Council of November 4, 2003 as implemented in each member State of the European Economic Area and amendments thereto, including Directive 2010/73/EU (the "Prospectus Directive").

This announcement does not, and shall not, in any circumstances constitute a public offering nor an invitation to the public in connection with any offer in any jurisdiction.

With respect to the member States of the European Economic Area which have implemented the Prospectus Directive, the Notes may only be offered under circumstances not requiring B&M Retail Value S.A. to publish a prospectus as provided under article 3(2) of the Prospectus Directive.

This communication does not constitute an offer to the public in the United Kingdom. No prospectus has been or will be approved in the United Kingdom in respect of the Notes. The distribution of this press release is not made, and has not been approved, by an "authorized person" within the meaning of Section 21(1) of the Financial Services and Markets Act 2000. As a consequence, this press release is directed only at persons who (i) are located outside the United Kingdom, (ii) have professional experience in matters relating to investments and fall within Section 19(5) ("investment professionals") of the Financial Services and Markets Act 2000 (Financial Promotions) Order 2005 (the "Order") , (iii) are persons falling within Article 49(2)(a) to (d) ("high net worth companies, unincorporated associations, etc.") of the Order or (iv) are persons to whom this communication may otherwise lawfully be communicated (all such persons together being referred to as "Relevant Persons"). The Notes are directed only at Relevant Persons and no invitation, offer or agreement to subscribe, purchase or otherwise acquire such Notes may be proposed or made other than with Relevant Persons. Any person other than a Relevant Person may not act or rely on this document or any provision hereof. This press release is not a prospectus which has been approved by the Financial Conduct Authority or any other United Kingdom regulatory authority for the purposes of Section 85 of the Financial Services and Markets Act 2000.

This press release does not constitute an offer to sell or the solicitation of an offer to buy the notes in any jurisdiction in which such offer, solicitation or sale would be unlawful. There will be no public offering of the notes. The notes are being offered only to qualified institutional buyers pursuant to Rule 144A under the U.S. Securities Act of 1933 (the "Securities Act") and outside the United States pursuant to Regulation S under the Securities Act. The Notes have not been and will not be registered under the Securities Act, or with any securities regulatory authority of any state or other jurisdiction in the United States, and may not be offered or sold, directly or indirectly, within the United States or to, or for the account or benefit of, U.S. persons, as such term is defined in Regulation S under the Securities Act ("Regulation S"), except pursuant to an exemption from or in a transaction not subject to the registration requirements of the Securities Act.

The distribution of this document in certain countries may constitute a breach of applicable law. The information contained in this document does not constitute an offer of securities for sale in the United States, Australia, Canada or Japan.

This press release may not be published, forwarded or distributed in the United States, Australia, Canada or Japan.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IODUOVBRBVAAURR
Date   Source Headline
18th Jan 202211:11 amRNSHolding(s) in Company
18th Jan 202211:01 amRNSDirector/PDMR Shareholding
14th Jan 20227:00 amRNSResult of Secondary Placing of Ordinary Shares
13th Jan 20224:45 pmRNSProposed Secondary Placing of Ordinary Shares
13th Jan 20221:05 pmRNSBlock listing Interim Review
6th Jan 20227:00 amRNSQ3 FY22 Trading Update
30th Dec 20214:58 pmRNSPost Stabilisation Notice
9th Dec 20217:00 amRNSSpecial Dividend
24th Nov 202111:02 amRNSDirector/PDMR Notice
17th Nov 20213:48 pmRNSPricing of Senior Secured Notes Offering
15th Nov 20218:16 amRNSLaunch of Senior Secured Notes Offering
11th Nov 20217:00 amRNSFY22 Interim Results
10th Nov 20214:19 pmRNSHolding(s) in Company
10th Nov 202111:42 amRNSResult of Ordinary General Meeting
30th Sep 20219:00 amRNSTotal Voting Rights
30th Sep 20219:00 amRNSOrdinary General Meeting
16th Sep 20219:26 amRNSDirector/PDMR Shareholding
8th Sep 20219:36 amRNSTrading Update
12th Aug 20217:00 amRNSBoard Appointment
4th Aug 20218:00 amRNSBlock Listing Application
3rd Aug 202111:12 amRNSDirector/PDMR Shareholding
2nd Aug 202110:32 amRNSTotal Voting Rights
29th Jul 202112:16 pmRNSResult of AGM
20th Jul 202112:35 pmRNSDirector Declaration
16th Jul 20218:00 amRNSDirector/PDMR Shareholding
14th Jul 202111:22 amRNSDirector/PDMR Shareholding
13th Jul 20219:00 amRNSBlock listing Interim Review
8th Jul 20217:00 amRNSTrading Statement
21st Jun 20217:00 amRNSAnnual Financial Report
3rd Jun 20217:00 amRNSBoard Change
3rd Jun 20217:00 amRNSPreliminary Results
15th Mar 202110:16 amRNSHolding(s) in Company
4th Mar 20217:00 amRNSTrading Update
1st Mar 20219:48 amRNSTotal Voting Rights
25th Feb 20219:20 amRNSDirector Declaration
22nd Feb 20215:06 pmRNSDirector/PDMR Securities
10th Feb 20212:16 pmRNSHolding(s) in Company
9th Feb 202110:05 amRNSHolding(s) in Company
27th Jan 20217:00 amRNSHolding(s) in Company
20th Jan 20213:17 pmRNSHolding(s) in Company
20th Jan 202111:02 amRNSHolding(s) in Company
15th Jan 20214:02 pmRNSHolding(s) in Company
14th Jan 202112:52 pmRNSDirector/PDMR Shareholding
13th Jan 20219:24 amRNSBlock listing Interim Review
12th Jan 202110:00 amRNSDirector Declaration
12th Jan 20217:00 amRNSResults of Placing
11th Jan 20215:22 pmRNSProposed Secondary Placing
7th Jan 20217:00 amRNSTrading Statement
29th Dec 20209:25 amRNSDirector/PDMR Securities
29th Dec 20209:18 amRNSDirector/PDMR Securities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.